These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17974992)

  • 1. Aromatase expression predicts survival in women with early-stage non small cell lung cancer.
    Mah V; Seligson DB; Li A; Márquez DC; Wistuba II; Elshimali Y; Fishbein MC; Chia D; Pietras RJ; Goodglick L
    Cancer Res; 2007 Nov; 67(21):10484-90. PubMed ID: 17974992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibitors in human lung cancer therapy.
    Weinberg OK; Marquez-Garban DC; Fishbein MC; Goodglick L; Garban HJ; Dubinett SM; Pietras RJ
    Cancer Res; 2005 Dec; 65(24):11287-91. PubMed ID: 16357134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.
    Mah V; Marquez D; Alavi M; Maresh EL; Zhang L; Yoon N; Horvath S; Bagryanova L; Fishbein MC; Chia D; Pietras R; Goodglick L
    Lung Cancer; 2011 Nov; 74(2):318-25. PubMed ID: 21511357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting aromatase and estrogen signaling in human non-small cell lung cancer.
    Márquez-Garbán DC; Chen HW; Goodglick L; Fishbein MC; Pietras RJ
    Ann N Y Acad Sci; 2009 Feb; 1155():194-205. PubMed ID: 19250205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase in human lung carcinoma.
    Verma MK; Miki Y; Sasano H
    Steroids; 2011 Jul; 76(8):759-64. PubMed ID: 21392519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.
    Skjefstad K; Grindstad T; Khanehkenari MR; Richardsen E; Donnem T; Kilvaer T; Andersen S; Bremnes RM; Busund LT; Al-Saad S
    Steroids; 2016 Sep; 113():5-13. PubMed ID: 27234503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of aromatase CYP19 and its relationship with parameters in NSCLC.
    Oyama T; Kagawa N; Sugio K; Uramoto H; Hatano O; Harada N; Kaneko K; Kawamoto T; Yasumoto K
    Front Biosci (Landmark Ed); 2009 Jan; 14(6):2285-92. PubMed ID: 19273201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition of aromatase alters the mechanical and rheological properties of non-small-cell lung cancer cell lines affecting cell migration.
    Giannopoulou E; Siatis KE; Metsiou D; Kritikou I; Papachristou DJ; Kalofonou M; Koutras A; Athanassiou G; Kalofonos HP
    Biochim Biophys Acta; 2015 Feb; 1853(2):328-37. PubMed ID: 25450981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer.
    Aresti U; Carrera S; Iruarrizaga E; Fuente N; Marrodan I; de Lobera AR; Muñoz A; Buque A; Condori E; Ugalde I; Calvo B; Vivanco GL
    PLoS One; 2014; 9(10):e109659. PubMed ID: 25310221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma.
    Verma MK; Miki Y; Abe K; Niikawa H; Sasano H
    Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S91-102. PubMed ID: 22313325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment.
    Miki Y; Suzuki T; Abe K; Suzuki S; Niikawa H; Iida S; Hata S; Akahira J; Mori K; Evans DB; Kondo T; Yamada-Okabe H; Sasano H
    Cancer Res; 2010 Aug; 70(16):6659-69. PubMed ID: 20710045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
    Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
    Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
    Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
    Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of estrogen actions in human lung cancer.
    Miki Y; Abe K; Suzuki S; Suzuki T; Sasano H
    Mol Cell Endocrinol; 2011 Jul; 340(2):168-74. PubMed ID: 21354461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.
    Pirker R; Pereira JR; von Pawel J; Krzakowski M; Ramlau R; Park K; de Marinis F; Eberhardt WE; Paz-Ares L; Störkel S; Schumacher KM; von Heydebreck A; Celik I; O'Byrne KJ
    Lancet Oncol; 2012 Jan; 13(1):33-42. PubMed ID: 22056021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
    Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H
    Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.
    Heilbroner SP; Xanthopoulos EP; Buono D; Huang Y; Carrier D; Shah A; Kim J; Corradetti M; Wright JD; Neugut AI; Hershman DL; Cheng SK
    Lung Cancer; 2019 Mar; 129():8-15. PubMed ID: 30797496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.